SCHEMBL7175383

SCHEMBL7175383

C=C(Cl)c1ccccc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.48
HPGD P15428 8/20 0.48
KDM4E B2RXH2 6/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
CA12 O43570 2/20 0.48
CA2 P00918 2/20 0.48
CA4 P22748 2/20 0.48
CA14 Q9ULX7 2/20 0.48
CA1 P00915 1/20 0.48
HMGB1 P09429 1/20 0.48
CA6 P23280 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
NAPRT Q6XQN6 1/20 0.48
HSD17B10 Q99714 6/20 0.46
MAPT P10636 4/20 0.46
TSHR P16473 2/20 0.46
LMNA P02545 4/20 0.45
ALOX15 P16050 4/20 0.45
NPC1 O15118 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4801020 0.78 HPGD (0.52) ALDH1A1HPGDKDM4ESMN1; SMN2CA12
SCHEMBL10736476 0.78 HPGD (0.56) ALDH1A1HPGDKDM4ESMN1; SMN2CA12
SCHEMBL12156371 0.77 ALDH1A1 (0.60) ALDH1A1HPGDSMN1; SMN2MAPTLMNA
SCHEMBL27303906 0.77 TRPA1 (0.54) ALDH1A1HPGDKDM4ESMN1; SMN2CA12
SCHEMBL3190837 0.76 HPGD (0.56) ALDH1A1HPGDKDM4ESMN1; SMN2CA12
SCHEMBL28252553 0.76 HPGD (0.50) ALDH1A1HPGDKDM4ESMN1; SMN2CA12
Salicylamide SCHEMBL27340552 0.75 KDM4E (0.79) ALDH1A1HPGDKDM4ESMN1; SMN2CA12
SCHEMBL12856009 0.74 HPGD (0.48) ALDH1A1HPGDKDM4ESMN1; SMN2CA12
SCHEMBL7027832 0.74 HPGD (0.48) ALDH1A1HPGDKDM4ESMN1; SMN2CA12
SCHEMBL12819640 0.74 HPGD (0.48) ALDH1A1HPGDKDM4ESMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 EP disclosed
US-6576400-B1 Acrylic ester polymer TORAY INDUSTRIES, INC. (JP) 2003-06-10 US disclosed
WO-2001066106-A1 A PHARMACEUTICAL COMPOSITION HAVING CHLOROGENIC ACID AS ACTIVE COMPONENT FOR PREVENTING OR TREATING THE DECLINING OF MALE REPRODUCTION CAPABILITY WOORICHEM TECH CO., LTD. (KR) 2001-09-13 WO disclosed
EP-1031880-A1 POSITIVE RADIATION-SENSITIVE COMPOSITION TORAY INDUSTRIES, INC. (JP) 2000-08-30 EP disclosed